Renin–Angiotensin–Aldosterone System (RAAS) Inhibitors in Patients with Covid-19

This review addresses concerns about use of RAAS inhibitors and explicitly highlights that withdrawal of RAAS inhibitors may be harmful in certain high-risk patients with known or suspected Covid-19.

Source:

New England Journal of Medicine